Susquehanna International Group
KURA icon

Susquehanna International Group’s Kura Oncology KURA Stock Holding History

Susquehanna International Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Sell
67,000
-60,600
-47% -$521K ﹤0.01% 9438
2025
Q4 		$1.33M Buy
127,600
+114,500
+874% +$1.2M ﹤0.01% 6539
2025
Q3 		$116K Sell
13,100
-9,600
-42% -$68.4K ﹤0.01% 11471
2025
Q2 		$131K Sell
22,700
-18,200
-44% -$112K ﹤0.01% 11605
2025
Q1 		$270K Sell
40,900
-21,600
-35% -$168K ﹤0.01% 10289
2024
Q4 		$544K Buy
62,500
+40,100
+179% +$577K ﹤0.01% 8460
2024
Q3 		$438K Sell
22,400
-57,800
-72% -$1.17M ﹤0.01% 8790
2024
Q2 		$1.65M Sell
80,200
-21,200
-21% -$436K ﹤0.01% 5472
2024
Q1 		$2.16M Buy
+101,400
New +$1.97M ﹤0.01% 5146
2023
Q3 		– Sell
-22,400
Closed -$237K – 12516
2023
Q2 		$237K Buy
22,400
+10,600
+90% +$125K ﹤0.01% 9926
2023
Q1 		$144K Sell
11,800
-11,500
-49% -$144K ﹤0.01% 10948
2022
Q4 		$289K Sell
23,300
-106,000
-82% -$1.54M ﹤0.01% 9181
2022
Q3 		$1.77M Buy
129,300
+71,800
+125% +$1.11M ﹤0.01% 5181
2022
Q2 		$1.05M Sell
57,500
-7,300
-11% -$105K ﹤0.01% 6398
2022
Q1 		$1.04M Sell
64,800
-36,700
-36% -$530K ﹤0.01% 7006
2021
Q4 		$1.42M Buy
+101,500
New +$1.64M ﹤0.01% 6337
2021
Q3 		– Sell
-131,500
Closed -$2.74M – 13184
2021
Q2 		$2.74M Sell
131,500
-138,000
-51% -$3.43M ﹤0.01% 5222
2021
Q1 		$7.62M Buy
269,500
+173,300
+180% +$5.48M ﹤0.01% 3211
2020
Q4 		$3.14M Buy
96,200
+51,200
+114% +$1.8M ﹤0.01% 4228
2020
Q3 		$1.38M Buy
45,000
+24,900
+124% +$550K ﹤0.01% 5354
2020
Q2 		$328K Buy
+20,100
New +$290K ﹤0.01% 8190
2020
Q1 		– Sell
-12,900
Closed -$177K – 10591
2019
Q4 		$177K Buy
+12,900
New +$191K ﹤0.01% 8848
2019
Q2 		– Sell
-32,900
Closed -$546K – 10562
2019
Q1 		$546K Buy
+32,900
New +$507K ﹤0.01% 6097
2018
Q4 		– Sell
-13,400
Closed -$235K – 9491
2018
Q3 		$235K Buy
13,400
+3,200
+31% +$61.3K ﹤0.01% 7939
2018
Q2 		$186K Buy
+10,200
New +$173K ﹤0.01% 8677

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's KURA Position: Q1 2026 in Review

Susquehanna International Group reduced its Kura Oncology (KURA) stake by 15% in Q1 2026, selling an estimated $154K and leaving 98,592 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #8470.

Susquehanna International Group first reported a position in KURA in Q1 2017 and has held it in 27 quarters since. The position peaked at $12.7M in Q1 2024. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Susquehanna International Group held 98,592 shares of Kura Oncology worth $802K as of Q1 2026.
  • Susquehanna International Group sold 17,921 Kura Oncology shares in Q1 2026, an estimated $154K.
  • Kura Oncology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8470 holding.
  • Susquehanna International Group first reported a position in Kura Oncology in Q1 2017 and has held it in 27 quarters since.
  • Susquehanna International Group's Kura Oncology position peaked at $12.7M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.